4CPS-206 Ribociclib as first line for metastasic breast cancer: analisis of use and security
| Autor: | T Chinchilla Alarcon, C Fernandez Cuerva, JD Paradas Palomo, I Muñoz Castillo |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Section 4: Clinical pharmacy services. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|